{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T12:05:21Z","timestamp":1777464321241,"version":"3.51.4"},"reference-count":41,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T00:00:00Z","timestamp":1704672000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bladder Cancer"],"published-print":{"date-parts":[[2024,1,8]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Cigarette smoking is the leading preventable cause of bladder cancer (BC). Some proponents of e-cigarettes describe their use as a risk mitigation strategy despite potential carcinogen exposure and uncertain long-term risks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>We assessed smoking cessation strategies, including e-cigarette use, and harm perception among patients with BC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>We performed a cross-sectional study on a convenience sample of patients with BC at a single institution from August 2021 \u2013October 2022. The survey instrument was sourced from the Cancer Patient Tobacco Use Questionnaire (C-TUQ) from the American Association for Cancer Research with standardized questions on tobacco use, cessation questions, and e-cigarette harm perceptions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>Of the 104 surveyed BC patients (mean age: 72 years; 27% female; 55% with muscle-invasive disease), 20% were current smokers (median pack years: 40) and 51% were former smokers (median pack years: 20). A minority (9%) had quit smoking at the time of diagnosis. Pharmacotherapy for smoking cessation included nicotine patches (25%), gum (21%), lozenges (8%), e-cigarettes (8%), and Varenicline\/Bupropion (4%). Notably, 43% of patients who continued to smoke expressed willingness to switch to e-cigarettes as a cessation aid. E-cigarette users (11%) more commonly perceived e-cigarettes as non-harmful compared to former (4%) and non-smokers (4%) ( P\u200a=\u200a.048), though all groups regarded e-cigarettes as equally addictive as traditional cigarettes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Despite the prevalence of BC survivors who continue to smoke, a significant proportion perceive e-cigarettes as a viable and less harmful cessation aid. The infrequent use of FDA-approved pharmacotherapies underscores potential implementation gaps. These findings highlight the need for further research and targeted interventions in addressing smoking cessation among BC survivors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3233\/blc-230093","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T11:13:44Z","timestamp":1708427624000},"page":"61-69","source":"Crossref","is-referenced-by-count":2,"title":["Patterns of Smoking Cessation Strategies and Perception of E-cigarette Harm Among Bladder Cancer Survivors"],"prefix":"10.1177","volume":"10","author":[{"given":"Jobin","family":"Chandi","sequence":"first","affiliation":[{"name":"School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srinath","family":"Soundararajan","sequence":"additional","affiliation":[{"name":"School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Bukowski","sequence":"additional","affiliation":[{"name":"Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wes","family":"Britt","sequence":"additional","affiliation":[{"name":"University of North Carolina at Chapel Hill, Chapel Hill, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin","family":"Weiss","sequence":"additional","affiliation":[{"name":"School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard S.","family":"Matulewicz","sequence":"additional","affiliation":[{"name":"Department of Surgery, Urology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Kay","sequence":"additional","affiliation":[{"name":"Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam O.","family":"Goldstein","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA"},{"name":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly A.","family":"Shoenbill","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA"},{"name":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA"},{"name":"Program on Health and Clinical Informatics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc A.","family":"Bjurlin","sequence":"additional","affiliation":[{"name":"Department of Urology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA"},{"name":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2024,2,19]]},"reference":[{"key":"ref001","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20000801)89:3<630::AID-CNCR19>3.0.CO;2-Q"},{"key":"ref002","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2014.11.001"},{"key":"ref003","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2020.10.006"},{"key":"ref004","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2016.11.006"},{"key":"ref005","doi-asserted-by":"publisher","DOI":"10.5489\/cuaj.10070"},{"issue":"5","key":"ref006","first-page":"513","volume":"106","author":"Gaddey HL","year":"2022","journal-title":"Am Fam Physician"},{"key":"ref007","unstructured":"MossanenM, SmithAB, OnochieN, MatulewiczR, BjurlinMA, KibelAS, AbbasM, ShoreN, ChisolmS, BangsR, CooperZ, GoreJLBladder cancer patient and provider perspectives on smoking cessation. Urol Oncol. 2023."},{"key":"ref008","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2023.0013"},{"key":"ref009","unstructured":"Canadian Cancer Society [homepage on the Internet] Toronto: The Society; [updated May 12, 2006; cited October 31, 2023. Available from:http:\/\/www.cancer.ca\/."},{"key":"ref010","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2020.12.033"},{"key":"ref011","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2020.02.004"},{"key":"ref012","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-19030-1"},{"key":"ref013","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-020-00410-2"},{"key":"ref014","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2022.03.019"},{"key":"ref015","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-16-0104"},{"key":"ref016","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2021.102037"},{"key":"ref017","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2015.0191"},{"key":"ref018","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2010.06.140"},{"key":"ref019","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2023.06.022"},{"key":"ref020","doi-asserted-by":"publisher","DOI":"10.21037\/tau-20-1204"},{"key":"ref021","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14164022"},{"key":"ref022","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.36.6518"},{"key":"ref023","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2014.06.002"},{"key":"ref024","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2017.179"},{"key":"ref025","doi-asserted-by":"publisher","DOI":"10.1159\/000507122"},{"key":"ref026","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-018-1046-8"},{"key":"ref027","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2023.04.003"},{"key":"ref028","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.44430"},{"key":"ref029","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-009218"},{"key":"ref030","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18168793"},{"key":"ref031","unstructured":"American Cancer Society Updates Position on Electronic Cigarettes: American Cancer Society; 2019 [updated November 19, 2019. Available from:https:\/\/pressroom.cancer.org\/eCigs2019."},{"key":"ref032","unstructured":"Cancer Research UK \u2013E-cigarette Policy Statement [press release]. Cancer Research UK, October 2019 2019."},{"key":"ref033","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntz043"},{"key":"ref034","doi-asserted-by":"publisher","DOI":"10.1111\/resp.13904"},{"key":"ref035","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(15)00521-4"},{"issue":"9","key":"ref036","first-page":"Cd015226","volume":"9","author":"Lindson N","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"ref037","doi-asserted-by":"publisher","DOI":"10.1093\/ntr\/ntw119"},{"key":"ref038","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2020.305999"},{"key":"ref039","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61842-5"},{"key":"ref040","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066317"},{"key":"ref041","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1808779"}],"container-title":["Bladder Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3233\/BLC-230093","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.3233\/BLC-230093","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3233\/BLC-230093","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:22:56Z","timestamp":1777382576000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.3233\/BLC-230093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,8]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1,8]]}},"alternative-id":["10.3233\/BLC-230093"],"URL":"https:\/\/doi.org\/10.3233\/blc-230093","relation":{},"ISSN":["2352-3727","2352-3735"],"issn-type":[{"value":"2352-3727","type":"print"},{"value":"2352-3735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,8]]}}}